On March 12, 2026, KingstronBio successfully performed the first implant of the ProStyle M® Transcatheter Mitral Valve System, marking a significant advancement in cardiac interventions.

KingstronBio's ProStyle M® transcatheter mitral valve system had its first successful implantation during a national multicenter study, marking a significant milestone.

The first implantation of KingstronBio's ProStyle M® valve system has been completed, heralding advancements in heart valve technology and patient care.

On March 12, 2026, KingstronBio successfully completed the first implantation of their ProStyle M® Transcatheter Mitral Valve System during a national multicenter study, marking a significant advancement in cardiac care.

KingstronBio has successfully completed the initial implant of their ProStyle M® Transcatheter Mitral Valve System during a multicenter study, marking a major advancement in heart valve technology.

KingstronBio has announced the successful first implant of their ProStyle M® Transcatheter Mitral Valve System. This key milestone showcases their commitment to innovation in cardiac healthcare.

The successful first implantation of KingstronBio's ProStyle M® Mitral Valve System heralds a significant advancement in cardiac treatments, enhancing patient care.

On March 12, 2026, KingstronBio successfully performed the first implant using its ProStyle M® Valve System, marking a new chapter in cardiac care. Following extensive studies, this innovative technology promises safer treatments for mitral regurgitation.